Linear β-1,3 Glucans Are Elicitors of Defense Responses in Tobacco von Olivier Klarzynski, Bertrand Plesse, Jean-Marie Joubert, Yvin, Jean-Claude, Marguerite Kopp, Kloareg, Bernard, Fritig, Bernard

Volltext

Sulfated fucan oligosaccharides elicit defense responses in tobacco and local and systemic resistance against tobacco mosaic virus von KLARZYNSKI, Olivier, DESCAMPS, Valérie, PLESSE, Bertrand, YVIN, Jean-Claude, KLOAREG, Bernard, FRITIG, Bernard

Volltext

Structure and promoter activity of a stress and developmentally regulated polyubiquitin-encoding gene of Nicotiana tabacum von Genschik, P., Marbach, J., Uze, M., Feuerman, M., Plesse, B., Fleck, J.

Volltext

Effects of the polyubiquitin gene Ubi. U4 leader intron and first ubiquitin monomer on reporter gene expression in Nicotiana tabacum von Plesse, B, Criqui, M C, Durr, A, Parmentier, Y, Fleck, J, Genschik, P

Volltext

Effects of the polyubiquitin gene Ubi.U4 leader intron and first ubiquitin monomer on reporter gene expression in Nicotiana tabacum von Plesse, Bertrand, Criqui, Marie-claire, Durr, Andrée, Parmentier, Yves, Fleck, Jacqueline, Genschik, Pascal

Volltext

Why are quiescent mesophyll protoplasts from Nicotiana sylvestris able to re-enter into the cell cycle and re-initiate a mitotic activity? von Durr, A., Jamet, E., Criqui, M.C., Genschik, P., Parmentier, Y., Marbach, J., Plesse, B., Lett, M.C., Vernet, T., Fleck, J.

Volltext

Linear beta -1,3 Glucans Are Elicitors of Defense Responses in Tobacco von Klarzynski, O, Plesse, B, Joubert, J, Yvin, J, Kopp, M, Kloareg, B, Fritig, B

Volltext

Characterization of genes expressed in mesophyll protoplasts of Nicotiana sylvestris before the re-initiation of the DNA replicational activity von Criqui, Marie-Claire, Plesse, Bertrand, Durr, Andrée, Marbach, Jacqueline, Parmentier, Yves, Jamet, Elisabeth, Fleck, Jacqueline

Volltext

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial von Ray-Coquard, I., Leary, A., Pignata, S., Cropet, C., González-Martín, A., Marth, C., Nagao, S., Vergote, I., Colombo, N., Mäenpää, J., Selle, F., Sehouli, J., Lorusso, D., Guerra Alia, E.M., Bogner, G., Yoshida, H., Lefeuvre-Plesse, C., Buderath, P., Mosconi, A.M., Lortholary, A., Burges, A., Medioni, J., El-Balat, A., Rodrigues, M., Park-Simon, T.-W., Dubot, C., Denschlag, D., You, B., Pujade-Lauraine, E., Harter, P.

Volltext

Laser-assisted lead extraction: the European experience von Kennergren, C., Bucknall, C.A., Butter, C., Charles, R., Fuhrer, J., Grosfeld, M., Tavernier, R., Morgado, T.B., Mortensen, P., Paul, V., Richter, P., Schwartz, T., Wellens, F.

Volltext

4D smart porous scaffolds based on the polyHIPE architecture and electroactive PEDOT von Ferrández-Montero, A, Carlier, B, Agniel, R, Leroy-Dudal, J, Vancaeyzeele, C, Plesse, C

Volltext

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer von Modi, Shanu, Jacot, William, Yamashita, Toshinari, Sohn, Joohyuk, Vidal, Maria, Tokunaga, Eriko, Tsurutani, Junji, Ueno, Naoto T., Prat, Aleix, Chae, Yee Soo, Lee, Keun Seok, Niikura, Naoki, Park, Yeon Hee, Xu, Binghe, Wang, Xiaojia, Gil-Gil, Miguel, Li, Wei, Pierga, Jean-Yves, Im, Seock-Ah, Moore, Halle C.F., Rugo, Hope S., Yerushalmi, Rinat, Zagouri, Flora, Gombos, Andrea, Kim, Sung-Bae, Liu, Qiang, Luo, Ting, Saura, Cristina, Schmid, Peter, Sun, Tao, Gambhire, Dhiraj, Yung, Lotus, Wang, Yibin, Singh, Jasmeet, Vitazka, Patrik, Meinhardt, Gerold, Harbeck, Nadia, Cameron, David A.

Volltext

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma von Flaherty, Keith T, Robert, Caroline, Hersey, Peter, Nathan, Paul, Garbe, Claus, Milhem, Mohammed, Demidov, Lev V, Hassel, Jessica C, Rutkowski, Piotr, Mohr, Peter, Dummer, Reinhard, Trefzer, Uwe, Larkin, James M.G, Utikal, Jochen, Dreno, Brigitte, Nyakas, Marta, Middleton, Mark R, Becker, Jürgen C, Casey, Michelle, Sherman, Laurie J, Wu, Frank S, Ouellet, Daniele, Martin, Anne-Marie, Patel, Kiran, Schadendorf, Dirk

Volltext

578P Tertiary cancer prevention: A national evaluation of the practices and perceptions of hospital-based health care professionals (HHCPs) in charge of the follow-up (FU) care of... von Ben Ahmed, T., Veron, L., Dubois-Delaloge, E., Pudlarz, T., Abdayem, P., Vidican, P., Petureau, A., Schillinger, P., Caron, O., Bensen, A., Boucher, S., Khettab, M., Heudel, P-E., Bernard, E., Lefeuvre-Plesse, C., Fervers, B., Luis, I. Vaz, Delaloge, S.

Volltext

1672P Single-dose NEPA versus 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with risk factors receiving moderately emetogen... von Zelek, L., Debourdeau, P., Bourgeois, H., Wagner, J.P., Brocard, F., Lefeuvre-Plesse, C., Chauffert, B., Leheurteur, M., Bachet, J-B., Simon, H., Mayeur, D., Jovenin, N., Scotté, F.

Volltext

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database von Carausu, M., Carton, M., Darlix, A., Pasquier, D., Leheurteur, M., Debled, M., Mouret-Reynier, M.A., Goncalves, A., Dalenc, F., Verret, B., Campone, M., Augereau, P., Ferrero, J.M., Levy, C., Fumet, J.-D., Lefeuvre-Plesse, C., Petit, T., Uwer, L., Jouannaud, C., Larrouquere, L., Chevrot, M., Courtinard, C., Cabel, L.

Volltext

176O Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagn... von Nagao, S., Harter, P., Leary, A., Cropet, C., Pignata, S., Fujiwara, K., Gonzalez Martin, A.J., Bogner, G., Vergote, I., Colombo, N., Maenpaa, J., Selle, F., Schmalfeldt, B., Scambia, G., Guerra Alia, E.M., Lefeuvre-Plesse, C., Belau, A., Lortholary, A., Gropp-Meier, M., Pujade-Lauraine, E., Ray-Coquard, I.

Volltext

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial von Ray-Coquard, I, Leary, A, Pignata, S, Cropet, C, Gonzalez-Martin, A, Marth, C, Nagao, S, Vergote, I, Colombo, N, Maenpaa, J, Selle, F, Sehouli, J, Lorusso, D, Alia, E.M. Guerra, Bogner, G, Yoshida, H, Lefeuvre-Plesse, C, Buderath, P, Mosconi, A.M, Lortholary, A, Burges, A, Medioni, J, El-Balat, A, Rodrigues, M, Park-Simon, T.-W, Dubot, C, Denschlag, D, You, B, Pujade-Lauraine, E, Harter, P

Volltext

LBA29 Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diag... von Ray-Coquard, I.L., Leary, A., Pignata, S., Cropet, C., Martin, A.J. Gonzalez, Bogner, G., Yoshida, H., Vergote, I.B., Colombo, N., Maenpaa, J., Selle, F., Schmalfeldt, B., Scambia, G., Alia, E.M. Guerra, Lefeuvre-Plesse, C., Belau, A., Lortholary, A., Gropp-Meier, M., Pujade-Lauraine, E., Harter, P.

Volltext

Single-dose NEPA versus 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with risk factors receiving moderately emetogenic che... von Zelek, L., Debourdeau, P., Bourgeois, H., Wagner, J. P., Brocard, F., Lefeuvre-Plesse, C., Chauffert, Bruno, Leheurteur, M., Bachet, J-B., Simon, H., Mayeur, D., Jovenin, N., Scotte, F.

Volltext